JP2011501941A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011501941A5 JP2011501941A5 JP2010514184A JP2010514184A JP2011501941A5 JP 2011501941 A5 JP2011501941 A5 JP 2011501941A5 JP 2010514184 A JP2010514184 A JP 2010514184A JP 2010514184 A JP2010514184 A JP 2010514184A JP 2011501941 A5 JP2011501941 A5 JP 2011501941A5
- Authority
- JP
- Japan
- Prior art keywords
- leucine
- amine
- acid
- alpha
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95866007P | 2007-07-06 | 2007-07-06 | |
| PCT/IB2008/002490 WO2009007849A2 (en) | 2007-07-06 | 2008-07-07 | Il-23 receptor antagonists and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011501941A JP2011501941A (ja) | 2011-01-20 |
| JP2011501941A5 true JP2011501941A5 (https=) | 2011-08-25 |
Family
ID=40229172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010514184A Withdrawn JP2011501941A (ja) | 2007-07-06 | 2008-07-07 | Ｉｌ−２３レセプターのアンタゴニストおよびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20100190710A1 (https=) |
| EP (1) | EP2288621A4 (https=) |
| JP (1) | JP2011501941A (https=) |
| CN (1) | CN101990547A (https=) |
| AU (1) | AU2008273814A1 (https=) |
| CA (1) | CA2692037A1 (https=) |
| IL (1) | IL202752A0 (https=) |
| WO (1) | WO2009007849A2 (https=) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130302343A1 (en) | 2011-01-04 | 2013-11-14 | Charité Universitätsmedizin Berlin | Modulators of il-12 and/or il-23 for the prevention or treatment of alzheimer's disease |
| GB2501219A (en) * | 2011-02-04 | 2013-10-16 | Aegis Therapeutics Llc | Orally bioavailable peptide drug compositions and methods thereof |
| US8946150B2 (en) | 2011-06-14 | 2015-02-03 | Medical Diagnostic Laboratories, LLC. | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof |
| US9605027B2 (en) * | 2011-06-14 | 2017-03-28 | Medical Diagnostic Laboratories, Llc | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof |
| USRE49026E1 (en) * | 2011-06-14 | 2022-04-12 | Medical Diagnostic Laboratories, Llc | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof |
| US20140221648A1 (en) * | 2011-06-27 | 2014-08-07 | Galderma Research & Developement | Th17 differentiation markers for acne and uses thereof |
| CN107012201A (zh) | 2011-06-27 | 2017-08-04 | 高德美研究及发展公司 | 用于痤疮的新th17分化标志物及其用途 |
| US9273093B2 (en) | 2012-10-11 | 2016-03-01 | Protagonist Therapeutics, Inc. | α4β7 peptide dimer antagonists |
| CZ304514B6 (cs) * | 2012-11-23 | 2014-06-11 | Biotechnologický Ústav Av Čr, V.V.I. | Polypeptidy pro léčbu autoimunitních chorob založenou na blokaci receptoru pro lidský cytokin IL-23 |
| DK2968443T3 (da) | 2013-03-15 | 2021-12-06 | Protagonist Therapeutics Inc | Hepcidinanaloger og anvendelser deraf |
| PT3143037T (pt) | 2014-05-16 | 2021-09-24 | Protagonist Therapeutics Inc | Antagonistas peptídicos tioéter de integrina alfa4beta7 |
| US9624268B2 (en) | 2014-07-17 | 2017-04-18 | Protagonist Therapeutics, Inc. | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| EP3201217A4 (en) | 2014-10-01 | 2018-07-18 | Protagonist Therapeutics Inc. | Novel cyclic monomer and dimer peptides having integrin antagonist activity |
| KR20170108936A (ko) | 2014-10-01 | 2017-09-27 | 프로타고니스트 테라퓨틱스, 인코포레이티드 | 신규한 α4β7 펩타이드 단량체 및 이량체 길항제 |
| HK1257747A1 (zh) * | 2015-07-15 | 2019-10-25 | Protagonist Therapeutics Inc. | 白细胞介素-23受体的肽抑制剂以及其治疗炎症性疾病的用途 |
| US10787490B2 (en) | 2015-07-15 | 2020-09-29 | Protaganist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| US20190002503A1 (en) | 2015-12-30 | 2019-01-03 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
| WO2017165676A1 (en) | 2016-03-23 | 2017-09-28 | Protagonist Therapeutics, Inc. | METHODS FOR SYNTHESIZING α4β7 PEPTIDE ANTAGONISTS |
| US20190270786A1 (en) * | 2016-07-27 | 2019-09-05 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 and their use to treat inflammatory diseases |
| EP3681900A4 (en) | 2017-09-11 | 2021-09-08 | Protagonist Therapeutics, Inc. | OPIOID AGONIST PEPTIDES AND THEIR USES |
| EP3749345A4 (en) | 2018-02-08 | 2022-04-06 | Protagonist Therapeutics, Inc. | CONJUGATED HEPCIDIN MIMETICS |
| CN108618100B (zh) * | 2018-05-10 | 2021-07-27 | 广东天企生物科技有限公司 | 一种具有鲜味和增鲜特性的四肽及其用途 |
| TW202019948A (zh) | 2018-07-12 | 2020-06-01 | 美商領導醫療有限公司 | 介白素-23受體之肽抑制劑及其治療發炎疾病之用途 |
| CN114341161A (zh) * | 2019-07-10 | 2022-04-12 | 领导医疗有限公司 | 白细胞介素-23受体的肽抑制剂及其用于治疗炎症性疾病的用途 |
| HRP20250769T1 (hr) | 2020-01-15 | 2025-08-29 | Janssen Biotech, Inc. | Peptidni inhibitori receptora za interleukin-23 i njihova uporaba u liječenju upalnih bolesti |
| AU2021209086A1 (en) | 2020-01-15 | 2022-08-04 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| AU2021383828A1 (en) | 2020-11-20 | 2023-07-06 | Janssen Pharmaceutica Nv | Compositions of peptide inhibitors of interleukin-23 receptor |
| WO2023288019A2 (en) | 2021-07-14 | 2023-01-19 | Janssen Biotech, Inc. | Lipidated peptide inhibitors of interleukin-23 receptor |
| CA3260606A1 (en) * | 2022-06-30 | 2024-01-04 | Sanofi | NEW PEPTIDES FOR USE AS SELECTIVE IL-23 RECEPTOR ANTAGONISTS |
| WO2026067838A1 (zh) * | 2024-09-30 | 2026-04-02 | 上海瀚辰星泰医药科技有限公司 | 一种多肽化合物及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000061165A1 (en) * | 1999-04-13 | 2000-10-19 | Smithkline Beecham Corporation | Conserved adhesin motif and methods of use thereof |
| WO2001023556A1 (en) * | 1999-09-27 | 2001-04-05 | Chugai Seiyaku Kabushiki Kaisha | Novel hemopoietin receptor protein, nr12 |
| BRPI0408247A (pt) * | 2003-03-10 | 2006-03-01 | Schering Corp | usos de antagonistas e agonistas de il-23 e reagentes relacionados |
| US20070178520A1 (en) * | 2004-02-27 | 2007-08-02 | Barbara Wolff-Winiski | Screening assay for modulators of interaction between interleukin-12 and/or -23 with their receptors |
| AU2006264567A1 (en) * | 2005-05-05 | 2007-01-11 | Valorisation Hsj, Societe En Commandite | Cytokine receptor modulators and uses thereof |
-
2008
- 2008-07-07 CN CN2008800236017A patent/CN101990547A/zh active Pending
- 2008-07-07 WO PCT/IB2008/002490 patent/WO2009007849A2/en not_active Ceased
- 2008-07-07 JP JP2010514184A patent/JP2011501941A/ja not_active Withdrawn
- 2008-07-07 CA CA2692037A patent/CA2692037A1/en not_active Abandoned
- 2008-07-07 US US12/666,028 patent/US20100190710A1/en not_active Abandoned
- 2008-07-07 EP EP08807150A patent/EP2288621A4/en not_active Withdrawn
- 2008-07-07 AU AU2008273814A patent/AU2008273814A1/en not_active Abandoned
-
2009
- 2009-12-15 IL IL202752A patent/IL202752A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011501941A5 (https=) | ||
| JP5961113B2 (ja) | Ｇａｄｄ４５β標的医薬 | |
| Botti et al. | Native chemical ligation using removable Nα-(1-phenyl-2-mercaptoethyl) auxiliaries | |
| JP2013500990A5 (https=) | ||
| US9534018B2 (en) | Melanocortin analogs having enhanced activity and transport | |
| JP2013155195A5 (https=) | ||
| CN101990547A (zh) | Il-23受体拮抗剂以及其应用 | |
| JP2007077163A (ja) | 新規カッパレセプター選択的オピオイドペプチド | |
| US20110262508A1 (en) | Antimicrobial compositions, formulations and uses thereof | |
| CA2656287A1 (en) | Inhibition of alpha-synuclein aggregation | |
| CN1050721A (zh) | 放射性标记的抗凝血多肽 | |
| US20170037105A1 (en) | Peptidomimetic macrocycles | |
| JP2020521784A5 (https=) | ||
| JP2008517998A5 (https=) | ||
| EP4137502A1 (en) | Vipr2 antagonist peptide | |
| DeGraw et al. | Stabilized analogs of thymopentin. 1. 4, 5-ketomethylene pseudopeptides | |
| Hill et al. | Enantioselection in peptide bond formation | |
| WO2007126111A1 (ja) | アミロイドβ線維化阻害ペプチド | |
| CN1039126C (zh) | 抗塔基奎宁的三环化合物,及含该化合物的药物组合物 | |
| EP1725580B1 (en) | Isosteric transformation | |
| Samant et al. | Norcystine, a new tool for the study of the structure− activity relationship of peptides | |
| CHOREV et al. | Effects of hydrophobic substitutions at position 18 on the potency of parathyroid hormone antagonists | |
| JP2005527491A5 (https=) | ||
| DeGraw et al. | Stabilized analogs of thymopentin. 2. 1, 2-and 3, 4-ketomethylene pseudopeptides | |
| JP2009520772A5 (https=) |